Trading window closed from July 1 ahead of Q1 FY27 results
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Orchid Pharma has informed exchanges that the trading window for its securities will be closed from July 1, 2026 until 48 hours after the board declares unaudited limited reviewed financial results (standalone and consolidated) for Q1 FY26-27 ending June 30, 2026. This is a routine compliance measure under SEBI insider trading rules to prevent insiders from trading during the quiet period before results. The board meeting date to approve results will be announced separately.
Routine regulatory compliance filing. Restricts insider trading till Q1 FY27 results are declared but has no direct impact on shareholders or stock price.